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As the life expectancy of ]apanese population has been increasing， how best to treat invasive 
bladder cancer in elderly patients has become a new problem. Generally standard treatment for 
locally advanced invasive bladder cancer is thought to be radical cystectomy， but that for elderly 
patients is stil controversial due to frequent presence of comorbid diseases. Here， we debate the 
merits and demerits of radical cystectomy and bladder preservation for elderly patients with locally 
advanced invasive bladder cancer. First， we presented the treatment outcome of 1，131 patients with 
invasive bladder cancer who underwent radical cystectomy in ]apan， toclarify the characteristics of 
invasive bladder cancer of elderly patients and to determine whether age had an impact on the clinical 
or functional results. Furthermore， toclarify the indication of the bladder preservation for elderly 
patients， we reviewed the results of recent trials. Several new trials of chemoradiotherapy have shown 
high response rates with low local morbidity but high systemic morbidity requiring dose reductions or 
treatment delay. This regimen may prove to be effective for inoperable patients and may be proposed 
as conservative treatment for patients with complete responses to the initial course of chemoradiation. 
Although chemoradiation shows promise， more trials are needed to clarify the morbidity and mortality 
rates of chemoradiation for elderly patients. 
(Hinyokika Kiyo 51 : 553-557， 2005) 
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検討した. 1， 131例における年齢分布をみると， 60-
80歳が最も多いが， 81歳以上の高齢者を対象とした腸
脱全摘症例は62例 (5%)しかなかった (Table1). 
一般に勝脱癌は年齢とともに発生しやすくなることを
Table 1. Patient characteristics stratified with 
age 
Age No. Gendtr Efi。stfoTioCECV JE:誌主Pts (%) % ofMale % 
国50 78 ( 6.9) 80.8 88目5 25.6 
51-60 229 (20.2) 86.0 90.8 26.2 
61-70 428 (37.8) 83.4 92.5 26.9 
71-80 334 (29.5) 73.7 93.4 34.1 
81- 62 ( 5.5) 64.5 91.9 35.5 
Total 1131 79目8 92.1 29‘3 
Table 2. Treatment strategy in elder patients 
Factors 
80 y.o.孟 81 y.o孟
No. Pts (%) No. Pts (%) 
LN -dissection 
with 979 (91.6) 37 (59.7) 
without 90 25 
Adjunctive chemotherapy 
with 385 (36.0) 4 ( 6.5) 
without 684 58 
Urinary undiversion 
ileal conduit 490 (45.8) 30 (48.4) 
ureterocutaneostomy 199 (18.6) 29 (46.8) 
kock/indiana-pouch 83 ( 7.8) o (0 ) 
Studer/Houtman 268 (25.1) o (0 ) 






































Table 3. Survival related with age 
DFuor(arilatoinowgn -eu} foV) No No. 
Overall survival 
Age No. Pts Recurrence (%) Death (%) 3-y. 5-y. 
-50 78 4目6(0.3-11.8) 20 (25.6) 15 (19.2) 83.3 76.5 
51同60 229 4.8 (0.1-11.9) 54 (23.6) 57 (24.9) 76目6 72.3 
61-70 428 4.7 (0.2-11目6) 109 (25.5) 126 (29.4) 75.4 69.3 
71-80 334 3.9 (0.ト10.3) 90 (26.9) 113 (33.8) 69.8 63.6 
81 62 3.1 (0.ト10.1) 15 (24.2) 26 (41.2) 56.2 56.2 
Total 1，131 4.4 (0.1-11.9) 288 (25.5) 337 (29.8) 73.5 68.0 
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